Xuefeng Bai
No.77 Puhe Road, Shenyang North New Area
Shenyang, 110122, China
Shenyang, 110122, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction to: MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).
Journal: Journal of experimental & clinical cancer research : CR
Published: March 13, 2022
Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.
Journal: Oncology letters
Published: October 11, 2019
FSIP1 binds HER2 directly to regulate breast cancer growth and invasiveness.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 05, 2017
MiR-302a/b/c/d cooperatively sensitizes breast cancer cells to adriamycin via suppressing P-glycoprotein(P-gp) by targeting MAP/ERK kinase kinase 1 (MEKK1).
Journal: Journal of experimental & clinical cancer research : CR
Published: November 02, 2015
Association between CD24-P226-C/T polymorphism and multiple sclerosis: a meta-analysis.
Journal: Immunological investigations
Published: May 06, 2015
The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells.
Journal: International journal of oncology
Published: January 15, 2014
[Retracted] The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK‑p53‑dependent mitochondrial apoptosis in breast cancer cells.
Journal: International journal of oncology
Published: January 15, 2014
DNA methyltransferase 1/3a overexpression in sporadic breast cancer is associated with reduced expression of estrogen receptor-alpha/breast cancer susceptibility gene 1 and poor prognosis.
Journal: Molecular carcinogenesis
Published: August 23, 2013
BRCA1 promoter hypermethylation in sporadic epithelial ovarian carcinoma: Association with low expression of BRCA1, improved survival and co-expression of DNA methyltransferases.
Journal: Oncology letters
Published: June 13, 2013
MYC overexpression and poor prognosis in sporadic breast cancer with BRCA1 deficiency.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: May 10, 2013
MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).
Journal: Breast cancer research and treatment
Published: March 26, 2013
Last Updated: 09/26/2026